Preferred Label : Osteosclerotic metaphyseal dysplasia;
Symbol : OSMD;
CISMeF acronym : OSMD;
Type : Phenotype, molecular basis known;
Description : Osteosclerotic metaphyseal dysplasia is a rare condition characterized by developmental
delay, hypotonia, and distinctive radiographic changes, including osteosclerosis localized
predominantly to the metaphyses of the long bones. The shafts of the long bones are
osteopenic. The skull appears to be spared. Seizures and later-onset spastic paraplegia
have been reported. Laboratory abnormalities include elevated alkaline phosphatase
levels in some, but not all, patients. Elevated urinary pyridinoline and deoxypyridinoline
levels, markers of osteoclastic activity, have also been reported (summary by Nishimura
and Kozlowski, 1993 and Kasapkara et al., 2013).;
Inheritance : Autosomal recessive;
Laboratory abnormalities : Elevated AST (aspartate aminotransferase) and CPK (creatine phosphokinase); Elevated alkaline phosphatase (in one patient); Elevated urinary pyridinoline and deoxypyridinoline;
Prefixed ID : #615198;
Origin ID : 615198;
UMLS CUI : C3554665;
- Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- Genes related to phenotype
- HPO term(s)
- Not associated HPO term(s)
- ORDO concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)